Theravance Biopharma (TBPH) Convertible Debt (2016 - 2022)
Theravance Biopharma's Convertible Debt came in at $228.57 million for Q2 2022, up 0.5% from $227.5 million a year earlier and up 0.1% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Convertible Debt (2016 - 2022) Analysis & Trends
At the end of FY2021, Theravance Biopharma's Convertible Debt was $228.04 million, up 0.5% from FY2020.
- Convertible Debt has increased in each of the last five years, with a five-year compound annual growth rate of 0.5% (FY2016 to FY2021).
- Going back by year, Convertible Debt was $226.96 million in FY2020 (+0.5%), $225.89 million in FY2019 (+0.5%), $224.82 million in FY2018 (+0.5%) and $223.75 million in FY2017 (+0.5%).
- The Q2 2022 figure represents the highest quarterly Convertible Debt in data going back to Q4 2016.
- Year-over-year, Convertible Debt has increased for 19 consecutive quarters, with growth averaging 0.5% over the last eight quarters.
- Business Quant data shows TBPH's Convertible Debt at $228.3 million (Q1 2022), $228.04 million (Q4 2021) and $227.77 million (Q3 2021) in the three quarters before Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 228.57 Mn |
| Mar 31, 2022 | 228.30 Mn |
| Dec 31, 2021 | 228.04 Mn |
| Sep 30, 2021 | 227.77 Mn |
| Jun 30, 2021 | 227.50 Mn |
| Mar 31, 2021 | 227.23 Mn |
| Dec 31, 2020 | 226.96 Mn |
| Sep 30, 2020 | 226.70 Mn |
| Jun 30, 2020 | 226.43 Mn |
| Mar 31, 2020 | 226.16 Mn |
| Dec 31, 2019 | 225.89 Mn |
| Sep 30, 2019 | 225.62 Mn |
| Jun 30, 2019 | 225.35 Mn |
| Mar 31, 2019 | 225.09 Mn |
| Dec 31, 2018 | 224.82 Mn |
| Sep 30, 2018 | 224.55 Mn |
| Jun 30, 2018 | 224.28 Mn |
| Mar 31, 2018 | 224.01 Mn |
| Dec 31, 2017 | 223.75 Mn |
| Sep 30, 2017 | 223.48 Mn |
API Access
Theravance Biopharma Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();